RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication
Artículo científico (JournalArticle)
Anti-Inflammatory and Anti-Fibrotic Profile of Fish Oil Emulsions Used in Parenteral Nutrition-Associated Liver Disease
[EN] Home parenteral nutrition (PN) is associated with many complications including severe hepatobiliary dysfunction. Commercial omega-6 fatty acid-soybean based-lipid emulsions in PN may mediate long term PN associate liver disease (PNALD) whereas omega-3-fish oil parenteral emulsions have shown to reverse PNALD in children. However, its clinical effectiveness in adults has been scarcely reported. In this work, we study the role of soybean and fish oil lipid commercial emulsions on inflammatory and profibrotic liver markers in adults with long term PNALD and in in vitro cellular models. Inflammatory and profibrotic markers were measured in serum of ten adults with long term PNALD and in culture supernatants of monocytes. Liver epithelial to mesenchymal transition (EMT) was induced by transforming growth factor beta 1 (TGF beta 1) to evaluate in vitro liver fibrosis. Omegaven (R), a 100% fish oil commercial emulsion, was infused during four months in two patients with severe long term PNALD reversing, at the first month, the inflammatory, profibrotic and clinical parameters of PNALD. The effect was maintained during the treatment course but impaired when conventional lipid emulsions were reintroduced. The other patients under chronic soybean oil-based PN showed elevated inflammatory and profibrotic parameters. In vitro human monocytes stimulated with lipopolysaccharide induced a strong inflammatory response that was suppressed by Omegaven (R), but increased by soybean emulsions. In other experiments, TGFb1 induced EMT that was suppressed by Omegaven (R) and enhanced by soybean oil lipid emulsions. Omegaven (R) improves clinical, anti-inflammatory and anti-fibrotic parameters in adults with long-term home PNALD., This work was supported by grants from "proyecots de investigacion fundamental no orientada (SAF) 2011-26443 (JC)'', "fondo de investigaciones sanitarias (FIS) CP11/00293(JM)'', "centro de investigacion biomedica en red de enfermedades respiratorias (CIBERES) CB06/06/0027'', Spanish Government ADE10/00020 (JC), as well as research grants from Regional Government Prometeo II/2013/014 (JC, JM) "Generalitat Valenciana.'' Support from the "centro para el desarrollo tecnologico e industrial (CENIT)'' programme (Spanish Government) was obtained. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.